| 2013 | | 5-Fluorouracil, mitomycin-c, and polysaccharide-k versus uracil-ftorafur and polysaccharide-K as adjuvant chemoimmunotherapy for patients with locally advanced gastric cancer with curative resection. | 강석윤, 박준성, 안미선, 이광재, 이순영, 이현우, 정성현, 조용관, 최진혁, 한상욱 |
| 2015 | | A multicenter analysis of adjuvant therapy after surgery for stage IIIC endometrial adenocarcinoma: A Korean Radiation Oncology Group study (KROG 13-17). | 전미선 |
| 2014 | | A phase 2 trial of radiation therapy with concurrent paclitaxel chemotherapy after surgery in patients with high-risk endometrial cancer: a Korean Gynecologic Oncologic Group study. | 유희석 |
| 2016 | | A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis | 정성현 |
| 2015 | | A prospective, multicenter, observational study of long-term decitabine treatment in patients with myelodysplastic syndrome. | 정성현 |
| 2018 | | Absolute Lymphocyte Count in Preoperative Chemoradiotherapy for Rectal Cancer: Changes Over Time and Prognostic Significance | 노오규, 오승엽, 오영택, 전미선, 조오연, 허재성 |
| 2014 | | Absolute monocyte count predicts overall survival in mantle cell lymphomas: correlation with tumour-associated macrophages. | 고영화 |
| 2020 | | Adding Ovarian Suppression to Tamoxifen for Premenopausal Breast Cancer: A Randomized Phase III Trial | 정용식, 한세환 |
| 2014 | | Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial | 최진혁 |
| 2016 | | Adjuvant Treatment after Surgery in Stage IIIA Endometrial Adenocarcinoma | 전미선 |
| 2020 | | Aggressive Surgical Excision of Supraclavicular Lymph Node Did Not Improve the Outcomes of Breast Cancer With Supraclavicular Lymph Node Involvement (KROG 16-14) | 전미선 |
| 2022 | | Analysis of treatment outcomes according to the cycles of adjuvant chemotherapy in gastric cancer: a retrospective nationwide cohort study | 강석윤, 김태환, 안미선, 이현우, 최용원, 최진혁 |
| 2005 | | Antiepileptic drug withdrawal after successful surgery for intractable temporal lobe epilepsy. | 허균 |
| 2021 | | Appropriate Number of Adjuvant Chemotherapy Cycles for Patients with Stage 2 or 3 Gastric Cancer After Curative Gastrectomy: A Multicenter Cohort Study | 허훈 |
| 2015 | | AROS Is a Significant Biomarker for Tumor Aggressiveness in Non-cirrhotic Hepatocellular Carcinoma. | 왕희정 |
| 2019 | | Association between 18F-FDG uptake in PET/CT, Nrf2, and NQO1 expression and their prognostic significance in non-small cell lung cancer | 고영화, 이수진, 한재호 |
| 2020 | | Association between survival and levetiracetam use in glioblastoma patients treated with temozolomide chemoradiotherapy | 노태훈 |
| 2022 | | BCL2 super-expressor diffuse large B-cell lymphoma: a distinct subgroup associated with poor prognosis | 노진, 정성현, 최윤석 |
| 2016 | | Blood Neutrophil-to-Lymphocyte Ratio Predicts Tumor Recurrence in Patients with Hepatocellular Carcinoma within Milan Criteria after Hepatectomy | 김봉완, 왕희정 |
| 2010 | | c-Met expression as an indicator of survival outcome in patients with oral tongue carcinoma. | 김철호, 이진석, 한재호 |
| 2017 | | Chemoradiotherapy versus surgery followed by postoperative radiotherapy in tonsil cancer: Korean Radiation Oncology Group (KROG) study | 오영택 |
| 2018 | | Chronologically changing patterns in the survival of korean patients with breast cancer and related clinical factors: a nationwide registry-based study | 정용식 |
| 2022 | | Clinical Characteristics and Treatment Outcomes of Childhood Acute Promyelocytic Leukemia in Korea: A Nationwide Multicenter Retrospective Study by Korean Pediatric Oncology Study Group | 최영배 |
| 2012 | | Clinical features and outcomes of Hodgkin's lymphoma in Korea: Consortium for Improving Survival of Lymphoma (CISL) | 박준성 |
| 2017 | | Clinical Impact of Escalating Relative High-dose-rate Intracavitary Brachytherapy Dose in Stage IIB Cervical Cancer | 노오규, 오영택, 장석준, 전미선, 조오연 |
| 2016 | | Clinical impact of high mobility group box 1 protein in epithelial ovarian cancer | 백지흠 |
| 2011 | | Clinical implication of bile spillage in patients undergoing laparoscopic cholecystectomy for gallbladder cancer. | 김명욱, 김봉완, 김욱환, 왕희정, 이재명 |
| 2021 | | Clinical Implications of Combined Lymphocyte and Neutrophil Count in Locally Advanced Rectal Cancer After Preoperative Chemoradiotherapy | 오승엽, 윤순석 |
| 2010 | | Clinical importance of morphological multilineage dysplasia in acute myeloid leukemia with myelodysplasia related changes. | 박서진 |
| 2003 | | Clinical significance of bone marrow micrometastasis detected by nested rt-PCR for keratin-19 in breast cancer patients. | 김명욱, 박준성, 박희붕, 소의영, 이국종, 임현이, 정용식 |
| 2022 | | Clinical Significance of Surgical Resection Timing from Endoscopic Stenting for Left-Sided Large-Bowel Obstruction in Colorectal Cancer | 오승엽, 임선교 |
| 2017 | | Clinicopathological Implication of Insulin-like Growth Factor-II mRNA-Binding Protein 3 (IMP3) Expression in Gastric Cancer | 이다근, 허훈 |
| 2014 | | Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline: randomized phase II multicenter trial. | 강석윤 |
| 2017 | | Comparison of anatomic and non-anatomic hepatic resection for hepatocellular carcinoma | 왕희정 |
| 2017 | | Conditional Survival Analysis Demonstrates that Recurrence Risk of Surgically Treated Hepatocellular Carcinoma Evolves with Time | 김봉완, 왕희정 |
| 2024 | | Correlation between Angiotensin Inhibitor Administration and Longer Survival in Patients Who Underwent Curative Resection for Pancreatic Cancer | 양혜연 |
| 2015 | | Correlation Between F-18 Fluorodeoxyglucose Positron Emission Tomography Metabolic Parameters and Dynamic Contrast-Enhanced MRI-Derived Perfusion Data in Patients with Invasive Ductal Breast Carcinoma. | 강두경, 김태희, 안영실, 윤준기, 이수진, 임현이, 정용식 |
| 2011 | | Current status of pediatric umbilical cord blood transplantation in Korea: a multicenter retrospective analysis of 236 cases. | 박준은, 정현주 |
| 2020 | | DeepBTS: Prediction of Recurrence-free Survival of Non-small Cell Lung Cancer Using a Time-binned Deep Neural Network | 이현우 |
| 2018 | | Differences in prognosis and efficacy of chemotherapy by p53 expression in triple-negative breast cancer | 정용식 |
| 2010 | | Differentiated thyroid carcinoma presenting with distant metastasis at initial diagnosis clinical outcomes and prognostic factors. | 소의영, 이잔디 |
| 2016 | | Echocardiographic epicardial fat thickness is a predictor for target vessel revascularization in patients with ST-elevation myocardial infarction | 박진선, 서경우, 신준한, 윤명호, 최병주, 최소연, 탁승제, 황교승 |
| 2018 | | Effect of the proximal anastomosis site on mid-term radial artery patency in off-pump coronary artery bypass | 김도정 |
| 2010 | | Efficacy of adjuvant gemcitabine-cisplatin chemotherapy: a comparative study between locally advanced transitional cell carcinoma of the bladder and upper urinary tract. | 김세중 |
| 2010 | | Efficacy of high-dose chemotherapy and autologous stem cell transplantation in patients with relapsed medulloblastoma: a report on the Korean Society for Pediatric Neuro-Oncology (KSPNO)-S-053 study. | 박준은 |
| 2013 | | Efficacy of neoadjuvant chemotherapy in patients with FIGO stage IB1 to IIA cervical cancer: an international collaborative meta-analysis. | 유희석 |
| 2017 | | Efficacy, Tolerability, and Biomarker Analyses of Once-Every-2-Weeks Cetuximab Plus First-Line FOLFOX or FOLFIRI in Patients With KRAS or All RAS Wild-Type Metastatic Colorectal Cancer: The Phase 2 APEC Study | 서광욱 |
| 2023 | | Endoscopic Stenting for Malignant Left-Sided Large-Bowel Obstruction in Patients with Colorectal Cancer: Evaluation according to Pathological Stage | 오승엽, 임선교 |
| 2002 | | Expression of multidrug resistance-associated protein1,P-glycoprotein, and thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection. | 김명욱, 김효철, 이기범, 임호영, 조용관, 주희재, 최진혁 |
| 2016 | | Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial | 한상욱 |
| 2012 | | Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study | 이현우 |
